Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 103.70
-3.60 (-3.36%)
Mar 9, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 95.52 billion as of March 9, 2026. Its market cap has increased by 76.78% in one year.
Market Cap
95.52B
Enterprise Value
92.59B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
103.70
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 95.52B, an increase of 415.11%. That is a compound annual growth rate of 32.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 95.52B | -8.23% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 261.29B |
| WuXi Biologics | 150.36B |
| Innovent Biologics | 144.54B |
| Sino Biopharmaceutical | 109.58B |
| Sichuan Kelun-Biotech Biopharmaceutical | 90.06B |
| RemeGen | 59.85B |
| 3SBio | 53.95B |
| Shanghai Henlius Biotech | 37.50B |